170 related articles for article (PubMed ID: 26146661)
1. Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.
Sanders ML; Karnes JH; Denny JC; Roden DM; Ikizler TA; Birdwell KA
Transplant Direct; 2015 May; 1(4):. PubMed ID: 26146661
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction model for cutaneous squamous cell carcinoma in adult cardiac allograft recipients.
Nair N; Hu Z; Du D; Gongora E
World J Transplant; 2021 Mar; 11(3):54-69. PubMed ID: 33816146
[TBL] [Abstract][Full Text] [Related]
3. Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer.
Peters FS; Peeters AMA; Mandaviya PR; van Meurs JBJ; Hofland LJ; van de Wetering J; Betjes MGH; Baan CC; Boer K
Clin Epigenetics; 2018; 10():81. PubMed ID: 29946375
[TBL] [Abstract][Full Text] [Related]
4. Parotid metastases of cutaneous squamous cell carcinoma in renal transplant recipients: Case series and literature review.
Mokos M; Bašić-Jukić N
Dermatol Ther; 2021 May; 34(3):e14907. PubMed ID: 33619803
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma.
Ingvar A; Smedby KE; Lindelöf B; Fernberg P; Bellocco R; Tufveson G; Höglund P; Adami J
Nephrol Dial Transplant; 2010 Aug; 25(8):2764-71. PubMed ID: 19729465
[TBL] [Abstract][Full Text] [Related]
6. Risk of Cutaneous Squamous Cell Carcinoma Development in Renal Transplant Recipients Is Independent of TMC/EVER Alterations.
Burger B; Spörri I; Stegmann DA; De Mesmaker J; Schaub S; Itin PH; Steiger J; Arnold AW
Dermatology; 2015; 231(3):245-52. PubMed ID: 26227733
[TBL] [Abstract][Full Text] [Related]
7. Disrupted regulation of serpinB9 in circulating T cells is associated with an increased risk for post-transplant skin cancer.
Peters FS; Peeters AMA; van den Bosch TPP; Mooyaart AL; van de Wetering J; Betjes MGH; Baan CC; Boer K
Clin Exp Immunol; 2019 Sep; 197(3):341-351. PubMed ID: 31059128
[TBL] [Abstract][Full Text] [Related]
8. Metastasis of cutaneous squamous cell carcinoma in organ transplant recipients and the immunocompetent population: is there a difference? a systematic review and meta-analysis.
Genders RE; Weijns ME; Dekkers OM; Plasmeijer EI
J Eur Acad Dermatol Venereol; 2019 May; 33(5):828-841. PubMed ID: 30793804
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Squamous Cell Carcinoma in Immunocompromised Patients-A Comparison between Different Immunomodulating Conditions.
Zavdy O; Coreanu T; Bar-On DY; Ritter A; Bachar G; Shpitzer T; Kurman N; Mansour M; Ad-El D; Rozovski U; Itchaki G; Sherman S; Azulay-Gitter L; Mizrachi A
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980651
[TBL] [Abstract][Full Text] [Related]
10. Demethylation of the TSDR is a marker of squamous cell carcinoma in transplant recipients.
Sherston SN; Vogt K; Schlickeiser S; Sawitzki B; Harden PN; Wood KJ
Am J Transplant; 2014 Nov; 14(11):2617-22. PubMed ID: 25250867
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous squamous cell carcinoma and mortality in end-stage renal disease.
Jung J; Waller JL; Tran S; Baer SL; Kheda M; Mohammed A; Padala S; Young L; Siddiqui B; Bollag WB
Am J Med Sci; 2023 Mar; 365(3):249-257. PubMed ID: 36403674
[TBL] [Abstract][Full Text] [Related]
12. Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients.
Van Meerhaeghe T; Baurain JF; Bechter O; Orte Cano C; Del Marmol V; Devresse A; Doubel P; Hanssens M; Hellemans R; Lienard D; Rutten A; Sprangers B; Le Moine A; Aspeslagh S
Front Nephrol; 2022; 2():1041819. PubMed ID: 37675002
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
[TBL] [Abstract][Full Text] [Related]
14. The impact of transplant rejection on cutaneous squamous cell carcinoma in renal transplant recipients.
Puza CJ; Myers SA; Cardones AR; Beasley GM; Mosca PJ
Clin Exp Dermatol; 2019 Apr; 44(3):265-269. PubMed ID: 29952022
[TBL] [Abstract][Full Text] [Related]
15. Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients.
Ilyas M; Zhang N; Sharma A
Dermatol Surg; 2018 Mar; 44(3):370-374. PubMed ID: 29517497
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous squamous cell carcinoma (cSCC) and immunosurveillance - the impact of immunosuppression on frequency of cSCC.
Plasmeijer EI; Sachse MM; Gebhardt C; Geusau A; Bouwes Bavinck JN
J Eur Acad Dermatol Venereol; 2019 Dec; 33 Suppl 8():33-37. PubMed ID: 31833604
[TBL] [Abstract][Full Text] [Related]
17. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens.
Jensen P; Hansen S; Møller B; Leivestad T; Pfeffer P; Geiran O; Fauchald P; Simonsen S
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):177-86. PubMed ID: 10025742
[TBL] [Abstract][Full Text] [Related]
18. Interventions After First Post-Transplant Cutaneous Squamous Cell Carcinoma: A Proposed Decision Framework.
Bottomley MJ; Massey PR; Thuraisingham R; Doyle A; Rao S; Bibee KP; Bouwes Bavinck JN; Jambusaria-Pahlajani A; Harwood CA
Transpl Int; 2022; 35():10880. PubMed ID: 36484063
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
20. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P
Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
